Lectin RCA-I specifically binds to metastasis-associated cell surface glycans in triple-negative breast cancer

Breast Cancer Research

Volumn 17, Issue 1, 2015, Pages

  Zhou, Shu Min ^a,b   Cheng, Li ^a,b   Guo, Shu Juan ^a,b   Wang, Yang ^b   Czajkowsky, Daniel M ^b   Gao, Huafang ^c   Hu, Xiao Fang ^b   Tao, Sheng Ce ^a,b  

^a Chinese National Human Genome Center at Shanghai   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLUTININ; CELL SURFACE PROTEIN; GLYCAN; MEMBRANE PROTEIN; PLANT LECTIN; RICINUS COMMUNIS AGGLUTININ I; STREPTAVIDIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; POLYSACCHARIDE; PROTEIN BINDING; RICINUS COMMUNIS AGGLUTININ-1;

ADULT; AGED; ARTICLE; BIOTINYLATION; BREAST CANCER CELL LINE; CANCER STAGING; CANCER SURVIVAL; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL SURFACE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INTRADUCTAL CARCINOMA; LECTIN BINDING; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; METASTASIS; METASTASIS POTENTIAL; MOLECULAR DIAGNOSIS; PROTEIN MICROARRAY; RICINUS COMMUNIS; SURVIVAL TIME; TANDEM MASS SPECTROMETRY; TISSUE MICROARRAY; TRIPLE NEGATIVE BREAST CANCER; CELL MEMBRANE; CELL MOTION; METABOLISM; PATHOLOGY; PROTEIN ANALYSIS; REPRODUCIBILITY; TUMOR CELL LINE;

CARRIER PROTEINS; CELL LINE, TUMOR; CELL MEMBRANE; CELL MOVEMENT; FEMALE; HUMANS; MEMBRANE GLYCOPROTEINS; NEOPLASM METASTASIS; PLANT LECTINS; POLYSACCHARIDES; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84926290072     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/s13058-015-0544-9     Document Type: Article

References (39)

1. Akhtari M, Mansuri J, Newman KA, Guise TM, Seth P. Biology of breast cancer bone metastasis. Cancer Biol Ther. 2008;7:3-9.
2. Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363:1938-48.
3. Teng YH, Tan WJ, Thike AA, Cheok PY, Tse GM, Wong NS, et al. Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy. Breast Cancer Res. 2011;13:R35.
4. Amir E, Ocana A, Freedman O, Clemons M, Seruga B. Chemotherapy: dose-dense treatment for triple-negative breast cancer. Nat Rev Clin Oncol. 2010;7:79-80.
5. Hama Y, Nakagawa K. Early distant relapse in early stage triple-negative breast cancer: usefulness of FDG-PET for diagnosis of distant metastases. Breast Cancer. 2013;20:191-93.
6. Carey L, Winer E, Viale G, Cameron D, Gianni L. Triple-negative breast cancer: disease entity or title of convenience? Nat Rev Clin Oncol. 2010;7:683-92.
7. Wu SK, Zhao X, Meng XY, Du M, Zhang SH, Wang T, et al. Analysis of chemotherapeutic efficacies in metastatic triple-negative breast cancer. Zhonghua Yi Xue Za Zhi. 2012;92:3001-3.
8. Kossowska B, Ferens-Sieczkowska M, Gancarz R, Passowicz-Muszynska E, Jankowska R. Fucosylation of serum glycoproteins in lung cancer patients. Clin Chem Lab Med. 2005;43:361-9.
9. Ochwat D, Hoja-Lukowicz D, Litynska A. N-glycoproteins bearing beta1-6 branched oligosaccharides from the A375 human melanoma cell line analysed by tandem mass spectrometry. Melanoma Res. 2004;14:479-85.
10. Steentoft C, Schjoldager KT, Clo E, Mandel U, Levery SB, Pedersen JW, et al. Characterization of an immunodominant cancer-specific O-glycopeptide epitope in murine podoplanin (OTS8). Glycoconj J. 2010;27:571-82.
11. Guo HB, Zhang Y, Chen HL. Relationship between metastasis-associated phenotypes and N-glycan structure of surface glycoproteins in human hepatocarcinoma cells. J Cancer Res Clin Oncol. 2001;127:231-6.
12. Graham ES, Woo KK, Aalderink M, Fry S, Greenwood JM, Glass M, et al. M1 muscarinic receptor activation mediates cell death in M1-HEK293 Cells. PLoS One. 2013;8:e72011.
13. Nyalwidhe JO, Betesh LR, Powers TW, Jones EE, White KY, Burch TC, et al. Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression. Proteomics Clin Appl. 2013;7:677-89.
14. Tao SC, Li Y, Zhou J, Qian J, Schnaar RL, Zhang Y, et al. Lectin microarrays identify cell-specific and functionally significant cell surface glycan markers. Glycobiology. 2008;18:761-9.
15. Hsu KL, Mahal LK. A lectin microarray approach for the rapid analysis of bacterial glycans. Nat Protoc. 2006;1:543-9.
16. Lu X, Kang Y. Efficient acquisition of dual metastasis organotropism to bone and lung through stable spontaneous fusion between MDA-MB-231 variants. Proc Natl Acad Sci U S A. 2009;106:9385-90.
17. Kang Y, Pantel K. Tumor cell dissemination: emerging biological insights from animal models and cancer patients. Cancer Cell. 2013;23:573-81.
18. Videira PA, Correia M, Malagolini N, Crespo HJ, Ligeiro D, Calais FM, et al. ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines. BMC Cancer. 2009;9:357.
19. Rambaruth ND, Greenwell P, Dwek MV. The lectin Helix pomatia agglutinin recognizes O-GlcNAc containing glycoproteins in human breast cancer. Glycobiology. 2012;22:839-48.
20. Nakamura H, Jasper MJ, Hull ML, Aplin JD, Robertson SA. Macrophages regulate expression of alpha1,2-fucosyltransferase genes in human endometrial epithelial cells. Mol Hum Reprod. 2012;18:204-15.
21. Limame R, Wouters A, Pauwels B, Fransen E, Peeters M, Lardon F, et al. Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays. PLoS One. 2012;7:e46536.
22. Rodrigues JR, Charris J, Camacho J, Barazarte A, Gamboa N, Nitzsche B, et al. N'-Formyl-2-(5-nitrothiophen-2-yl)benzothiazole-6-carbohydrazide as a potential anti-tumour agent for prostate cancer in experimental studies. J Pharm Pharmacol. 2013;65:411-22.
23. Seth A, Cui J, To E, Kwee M, Matsubara J. Complement-associated deposits in the human retina. Invest Ophthalmol Vis Sci. 2008;49:743-50.
24. Cameron AM. AFP in OLT for HCC?: another shadow on the cave wall: comment on "evaluation of absolute serum alpha-fetoprotein levels in liver transplant for hepatocellular cancer". Arch Surg. 2011;146:33-4.
25. Mitsutsuji M, Takase N, Kamoda Y, Okamoto Y, Nishimura K, Oshikiri T, et al. A case of AFP-producing gastric carcinoma, in which liver metastases were eliminated successfully underwent total gastrectomy after chemotherapy. Gan To Kagaku Ryoho. 2010;37:1113-6.
26. He J, Liu Y, Xie X, Zhu T, Soules M, DiMeco F, et al. Identification of cell surface glycoprotein markers for glioblastoma-derived stem-like cells using a lectin microarray and LC-MS/MS approach. J Proteome Res. 2010;9:2565-72.
27. Cao R, Chen K, Song Q, Zang Y, Li J, Wang X, et al. Quantitative proteomic analysis of membrane proteins involved in astroglial differentiation of neural stem cells by SILAC labeling coupled with LC-MS/MS. J Proteome Res. 2012;11:829-38.
28. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003;3:537-49.
29. Lu X, Wang Q, Hu G, Van Poznak C, Fleisher M, Reiss M, et al. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev. 2009;23:1882-94.
30. Yang L, Nyalwidhe JO, Guo S, Drake RR, Semmes OJ. Targeted identification of metastasis-associated cell-surface sialoglycoproteins in prostate cancer. Mol Cell Proteomics. 2011;10:M110 007294.
31. Sehgal P, Kumar N, Praveen Kumar VR, Patil S, Bhattacharya A, Vijaya Kumar M, et al. Regulation of protumorigenic pathways by Insulin like growth factor binding protein2 and its association along with beta-catenin in breast cancer lymph node metastasis. Mol Cancer. 2013;12:63.
32. Ohara M, Shigematsu H, Tsutani Y, Emi A, Masumoto N, Ozaki S, et al. Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer - Usefulness for malignant grade of triple-negative breast cancer. Breast. 2013;22:958-63.
33. Fuster MM, Esko JD. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer. 2005;5:526-42.
34. Laubli H, Borsig L. Selectins promote tumor metastasis. Semin Cancer Biol. 2010;20:169-77.
35. Miao B, Skidan I, Yang J, You Z, Fu X, Famulok M, et al. Inhibition of cell migration by PITENINs: the role of ARF6. Oncogene. 2012;31:4317-32.
36. Cavallaro U, Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer. 2004;4:118-32.
37. Lee Y, Ise T, Ha D, Saint Fleur A, Hahn Y, Liu XF, et al. Evolution and expression of chimeric POTE-actin genes in the human genome. Proc Natl Acad Sci U S A. 2006;103:17885-90.
38. Zhou S-M, Cheng L, Guo S-J, Zhu H, Tao S-C. Lectin microarrays: a powerful tool for glycan-based biomarker discovery. Comb Chem High Throughput Screen. 2011;14:711-9.
39. Hirabayashi J, Yamada M, Kuno A, Tateno H. Lectin microarrays: concept, principle and applications. Chem Soc Rev. 2013;42:4443-58.